Cancer cell plasticity contributes to tumor therapy resistance and metastasis formation, which represent the main causes of cancer-related death for most cancers, including breast cancer. The tumor microenvironment drives cancer cell plasticity and metastasis and unravelling the underlying cues may provide novel effective strategies to manage metastatic disease. Here we show that stem cell antigen-1 positive (Sca-1+) murine breast cancer cells enriched during tumor progression and metastasis have higherin vitrocancer stem cell-like properties, enhancedin vivometastatic ability, and initiate primary tumors rich in Gr1highCD11b+Ly6Clowcells. In turn, tumor-educated Gr1+CD11b+(Tu-Gr1+CD11b+) cells rapidly and transiently convert low metastatic 4T1-Sca-1-cells into highly metastatic 4T1-Sca-1+cells via secreted OSM and IL6. Moreover, chemotherapy-resistant and highly metastatic 4T1-derived cells maintain high Sca-1+frequency through cell autonomous IL6 production. Inhibition of OSM, IL6 or JAK suppressed Tu-Gr1+CD11b+-induced Sca-1+population enrichmentin vitro, while JAK inhibition abrogated metastasis of chemotherapy-enriched Sca-1+cellsin vivo. Importantly, Tu-Gr1+CD11b+cells invoked a gene signature in tumor cells predicting shorter OS and RFS in breast cancer patients. Collectively, our data identified OSM/IL6-JAK as a clinically relevant paracrine/autocrine axis instigating breast cancer cell plasticity triggering metastasis.